Clinical Study

Detection of Autoantibodies against Recombinant Desmoglein 1 and 3 Molecules in Patients with Pemphigus vulgaris: Correlation with Disease Extent at the Time of Diagnosis and during Follow-Up

Table 3

Autoantibodies titres during follow-up. Values above the cutoff point of 20 Unit/mL are indicated in bold.

NameDateDSG 1DSG 3SkinMucosal

16/12/0317,437,95++
A.A. (PV mucocutaneous)24/04/0494.5626,09++
20/01/0560.921,92+
22/03/0716,801+
C.R. (PV mucous)12/04/0720,2654,67+
25/10/0712,77
20/12/06130,66++
C.G. (PV mucous)06/06/07063,13
31/10/070122,82
C.S. (PV mucocutaneous)14/03/0586,92168,43++++
18/10/0698,42198,97++
F.S. (PV mucocutaneous)04/09/03140,97250,17++++++
27/11/0325,76189,19+
02/03/040200,1
26/08/04034,28
20/12/04054,52
07/05/05190,22
05/09/05075,99
13/01/061,2985,7
P.E. (PV mucocutaneous)19/09/044,8272+++
01/09/051,464+
21/12/0574,52161,04+++
R.D. (PV mucous)07/03/0619,06121,32++
18/10/063179,78
03/12/03179,55222,7++++++
19/12/030140,06++++++
19/01/0450,88114,4++++
27/02/0438143,9++
03/06/04165,27164,95++
R.L. (PV mucocutaneous)14/03/0588,2195,69+
18/05/05135,38131,07+
20/06/06106,61140,48+
04/10/06148,44159,12++
24/01/07113,63139,87+
30/05/07124,23154++
09/03/053,96169,69++
R.S. (PV mucous)23/05/070256,8++
19/03/080175,69+
T.E. (PV mucous)01/09/063,3538,34+
28/02/07126,58
17/12/0762,82107,21++++++
V.I. (PV mucocutaneous)06/02/0856,73193,26+++++
13/05/0827,59179,46+
V.M. (PV cutaneous) Transition from pemphigus vulgaris to pemphigus foliaceous26/10/0685,19106,25+++
23/05/071900++
16/05/08144,60+
Z.P. (PV cutaneous) Transition from pemphigus vulgaris to pemphigus foliaceous29/06/05126,7441,08+
09/11/0574,1110+
15/03/06115,539,07++
26/07/06163,3417,78++
14/03/0780,4811,87+